Holen Sie sich die Stockscreener-App
14.95
2.75%
0.40
Handel nachbörslich:
14.97
0.02
+0.13%
Schlusskurs vom Vortag:
$14.55
Offen:
$14.55
24-Stunden-Volumen:
3.89M
Relative Volume:
1.21
Marktkapitalisierung:
$3.57B
Einnahmen:
$474.17M
Nettoeinkommen (Verlust:
$208.93M
KGV:
17.60
EPS:
0.8493
Netto-Cashflow:
$65.61M
1W Leistung:
+6.86%
1M Leistung:
-7.20%
6M Leistung:
-28.50%
1J Leistung:
-8.67%
1-Tages-Spanne:
$14.44
$15.41
1-Wochen-Bereich:
$13.82
$15.41
52-Wochen-Spanne:
$13.82
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Firmenname
Adma Biologics Inc
Sektor
Branche
Telefon
(201) 478-5552
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Vergleichen Sie ADMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
14.95 | 3.47B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-19 | Fortgesetzt | Raymond James | Strong Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Eingeleitet | Jefferies | Buy |
| 2019-04-15 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-12-11 | Bestätigt | Maxim Group | Buy |
| 2017-11-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2016-08-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2016-07-25 | Bestätigt | Maxim Group | Buy |
| 2015-05-13 | Bestätigt | Maxim Group | Buy |
| 2014-12-08 | Eingeleitet | Oppenheimer | Outperform |
| 2014-12-01 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
How Analyst Upgrades and Rising EPS Expectations at ADMA Biologics (ADMA) Have Changed Its Investment Story - Sahm
Sentiment analysis tools applied to ADMA Biologics Inc.Weekly Trading Summary & Advanced Swing Trade Entry Alerts - newser.com
Will ADMA Biologics Inc. rebound enough to break evenRate Cut & Reliable Breakout Forecasts - newser.com
Can ADMA Biologics Inc. stock attract ESG capital inflows2025 Short Interest & Community Verified Trade Signals - newser.com
What momentum shifts mean for ADMA Biologics Inc.Portfolio Return Report & AI Powered Market Entry Ideas - newser.com
Volume spikes in ADMA Biologics Inc. stock – what they mean2025 Top Gainers & Fast Gain Stock Tips - newser.com
Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True? - sharewise.com
Applying Wyckoff theory to ADMA Biologics Inc. stockPortfolio Performance Summary & Short-Term Swing Trade Alerts - newser.com
ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a Potential 99.86% Upside in the Biotech Space - DirectorsTalk Interviews
Comparing ADMA Biologics Inc. in custom built stock radarsInsider Selling & Precise Buy Zone Tips - newser.com
Is ADMA Biologics Quietly Building Toward $1.1 Bln Revenue Breakout? - RTTNews
Can momentum traders help lift ADMA Biologics Inc.Trade Risk Assessment & Reliable Breakout Stock Forecasts - newser.com
Adma Biologics (ADMA) Stock Moves -1.36%: What You Should Know - sharewise.com
Investors Heavily Search ADMA Biologics Inc (ADMA): Here is What You Need to Know - sharewise.com
Using data filters to optimize entry into ADMA Biologics Inc.Weekly Profit Recap & High Win Rate Trade Tips - newser.com
What moving averages say about ADMA Biologics Inc.2025 Retail Activity & Safe Entry Point Alerts - newser.com
Is ADMA Biologics Inc. stock oversold or undervaluedMarket Volume Summary & Fast Exit/Entry Strategy Plans - newser.com
Using flow based indicators on ADMA Biologics Inc.Trade Volume Report & Weekly High Potential Stock Alerts - newser.com
Weiss Ratings Reaffirms Buy (B-) Rating for ADMA Biologics (NASDAQ:ADMA) - MarketBeat
Can ADMA Biologics Inc. stock beat market expectations this quarter2025 Support & Resistance & Daily Risk Controlled Trade Plans - newser.com
Should you wait for a breakout in ADMA Biologics Inc.Rate Hike & Verified Chart Pattern Signals - newser.com
What MACD and RSI say about ADMA Biologics Inc.2025 Dividend Review & Scalable Portfolio Growth Ideas - newser.com
Is ADMA Biologics Inc. stock trading near support levels2025 Big Picture & Real-Time Stock Entry Alerts - newser.com
Tick level data insight on ADMA Biologics Inc. volatilityJuly 2025 Outlook & Consistent Profit Alerts - newser.com
1,800,440 Shares in ADMA Biologics Inc $ADMA Bought by Vaughan Nelson Investment Management L.P. - MarketBeat
Evaluating ADMA Biologics Inc. with trendline analysisQuarterly Earnings Report & Risk Managed Investment Entry Signals - newser.com
Why Adma Biologics (ADMA) Outpaced the Stock Market Today - sharewise.com
What analysts say about ADMA Biologics Inc stockRisk Mitigation Techniques & Analyze Your Portfolio Risk in Seconds - earlytimes.in
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 5.1%Here's Why - MarketBeat
ADMA Biologics Inc (ADMA) Stock Analysis: A Promising 86.16% Upside in the Biotech Sector - DirectorsTalk Interviews
ADMA Biologics Inc (ADMA) Stock Analysis: Exploring An 86.16% Potential Upside - DirectorsTalk Interviews
Assenagon Asset Management S.A. Sells 387,872 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Adma Biologics Inc-Aktie (ADMA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Grossman Adam S | President and CEO |
Sep 15 '25 |
Sale |
16.13 |
21,000 |
338,730 |
2,025,850 |
| Grossman Adam S | President and CEO |
Aug 15 '25 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,052,850 |
| Grossman Adam S | President and CEO |
Aug 15 '25 |
Sale |
16.88 |
21,000 |
354,480 |
2,031,850 |
| Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance |
Jul 30 '25 |
Option Exercise |
8.98 |
2,500 |
22,450 |
489,898 |
| Grossman Adam S | President and CEO |
Jul 15 '25 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,058,850 |
| Grossman Adam S | President and CEO |
Jul 15 '25 |
Sale |
18.66 |
21,000 |
391,860 |
2,037,850 |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):